Chief Medical Officer Summit 360º

We are pleased to welcome Dr Julie Krop, CMO, EVP, Clinical Development and Regulatory Affairs, AMAG Pharmaceuticals, Dr Zain Kassam, Co-Founder, EVP, Clinical Development and Translational Medicine, Finch Therapeutics and Dr Beth Garner, CMO, ObsEva as co-chairs for the 2021 CMO Summit.

This conference is dedicated to accomplishing two goals:
1) To bring together CMO and R&D executives to address the unique challenges associated with directing and managing all R&D functions with limited resources, while raising capital and strategizing for appropriate exits.
2) To create a network of CMOs and R&D Leadership from small to mid-size life science companies to share ideas, solutions and support.

Key Topic Areas for 2021:
The Impact of Innovation on Drug Development Operations
The Realities of Transitioning from Brick-and-Mortar Trial Sites to DCTs
Effective Outsourcing that Truly Supports Development Goals
Building a Long-Term and Global Regulatory Strategy
Structuring and Managing a Team Post-COVID
Creative Hiring Strategies with Remote Working and a Tight Job Market
CMO Preparation for Investor Interactions
The First 90 Days in a CMO Role